`

Mersana Therapeutics

Biotechnology Research

Specialities :
Cancer research
Antibody drug conjugates
Drug development
Bioconjugation
And oncology
revenue-icon Revenue
11M - 100M
funding-icon Total Funding
$100.0M
size-icon Size
51 - 200

Frequently Asked Questions About Mersana Therapeutics

What does Mersana therapeutics do?+

At Mersana, we have a passion for advancing therapies to make a significant impact in the lives of people living with cancer. Mersana Therapeutics is a clinical-stage biopharmaceutical company focused on the development of novel antibody-drug conjugates (ADCs) and driven by the knowledge that patients are waiting for new treatment options. The company has developed proprietary cytotoxic (Dolasynthen) and immunostimulatory (Immunosynthen) ADC platforms that are generating a pipeline of wholly-owned and partnered product candidates with the potential to treat a range of cancers. Its pipeline includes XMT-1660, a Dolasynthen ADC targeting B7-H4, and XMT-2056, an Immunosynthen ADC targeting a novel...

What are Mersana therapeutics's specialties? +

Cancer research,antibody drug conjugates,drug development,bioconjugation,and oncology

What is Mersana therapeutics's industry? +

Mersana therapeutics operates in the Biotechnology research industry.

What is Mersana therapeutics's revenue? +

Mersana therapeutics's revenue is 11m - 100m

What is Mersana therapeutics's company size? +

Mersana therapeutics has 51 - 200 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.